OpenEvidence Raises $200M in Series C Funding, Plans to Create "ChatGPT for Doctors"
Healthcare Brew
|
Contributed by: Drex DeFord
Summary
OpenEvidence, a startup established in 2022, is developing a platform that allows healthcare professionals to quickly access verified medical information, positioning itself as "ChatGPT for doctors." By focusing on high-quality research from reputable sources like The Lancet and Nature Medicine, the tool aims to enhance the efficiency and accuracy of clinical decision-making. Having secured $200 million in Series C funding, with a valuation of $6 billion, OpenEvidence highlights the growing demand for reliable healthcare AI technologies, which are projected to expand significantly in the coming years. Access is limited to verified clinicians, ensuring the integrity of information and preventing misuse by patients.
